Researchers from across campus recently crowded Cooper Auditorium to learn more about their colleagues’ work — and to look for creative ways to combine their efforts.
Graduate student Krist Azizian discusses research on stem cells and microRNA at a recent poster session. (Photo by p.cunningham) |
The second annual City of Hope Poster Session, “Collaborations: Synergy for Success,” presented a forum for clinical, laboratory and other researchers to share their most recent findings with other City of Hope investigators. The July 24 event aimed to encourage partnerships.
“The extraordinary opportunities that exist on our campus are best leveraged when scientists collaborate across individual barriers to offer future patients the benefits of both the laboratory and clinical research efforts,” said Robert Figlin, M.D., Arthur and Rosalie Kaplan Professor of Medical Oncology and acting cancer center director.
Figlin joined Alexandra Levine, M.D., chief medical officer, and Richard Jove, Ph.D., director of Beckman Research Institute, to thank and commend the research presenters.
Said Levine to the crowd of 350 scientists: “You have the audacity to ask the hard questions, the perseverance to look for the answers and the courage to publish your results for others to scrutinize, and for that I admire you.”
The poster session featured prizes for the best posters in four categories: graduate students, clinical fellows and residents, postdoctoral fellows and — new this year — researchers with bachelor’s or master’s degrees. Nearly 50 faculty members judged the posters based on their content, design and appearance, as well as each presenter’s knowledge and presentation skills.
Topics ranged from neurosciences to stem cell biology to cancer survivorship issues.
Jove extolled the value of friendly, collaborative competition. “First, it motivates us all to do our best; second, it gives us the satisfaction of doing our best; and third, we can enjoy and benefit from the success of others,” he said.
The City of Hope Poster Session aims to promote interdisciplinary collaboration and networking between clinicians, scientists and other researchers from all departments across the organization. The Postdoctoral Studies Office spearheads the annual event.
Premier posters First- and second-place winners from four categories at City of Hope's second annual poster session received cash awards of $1,000 and $500, respectively. Prizes went to these winners: | Category | | First place ($1,000) | | Second place ($500) | | | | | | | | Graduate students | | Enhance expression of microRNA-125b and its role in inflammatory gene expression and metabolic memory in vascular smooth muscle cells of diabetic mice; Louisa Villeneuve, Ph.D., Diabetes, Endocrinology & Metabolism Interferon-γ augments induction of regulatory T cells through tissue expression of B7-H1 and ameliorates chronic graft versus host disease; Tangsheng Yi, Ph.D., Diabetes, Endocrinology & Metabolism
Tie - $750 each | | Design and development of masked therapeutic antibodies to limit off-target effects: Application to anti-EGFR antibodies; Joshua Donaldson, Molecular Medicine
Understanding the molecular controls in normal and tumor stem cells of the brain; Jun Wang, Neurosciences
Tie - $500 each | | | | | | | | Postdoctoral fellows | | Modulation of alternative splicing reveals new insights into the role of CEACAM1 isoforms in human cancer; Chunnian Zhao, Ph.D., Neurosciences | | Assessment of the peritumoral microenvironment following craniotomy using intracerebral microdialysis; Beth Singer, Ph.D., Urology Research | | | | | | | | Clinical fellows and residents | | Invasive mold infections in hematopoietic cell transplantation; Marissa Kim, Pharm.D., Inpatient Pharmacy | | Nontuberculous mycobacterial (NTM) infections among hematopoietic cell transplant (HCT) recipients; Michelle Yu, Pharm.D., Inpatient Pharmacy | | | | | | | | Bachelor’s or master’s degree | | Induction of anti-glioma memory-NK cell response following multiple low-dose intracerebral CpG therapies; Darya Alizadeh, Neurosurgery | | The use of TISSEEL as a delivery vehicle for genetically engineered cytotoxic T lymphocytes; Erin Denny, Neurosurgery |
|